ÖZDEMİR IŞIK, Ö. Et Al. 2023. AB0016 HEPATITIS B SEROPREVALENCE AND REACTIVATION FREQUENCY IN PATIENTS USING BIOLOGICAL DRUGS OTHER THAN RITUXIMAB; SINGLE CENTER RESULTS. EULAR 2023 , (Milan, Italy), 1187-1183.

ÖZDEMİR IŞIK, Ö., TEMİZ KARADAĞ, D., YAZICI, A., & ÇEFLE, A., (2023). AB0016 HEPATITIS B SEROPREVALENCE AND REACTIVATION FREQUENCY IN PATIENTS USING BIOLOGICAL DRUGS OTHER THAN RITUXIMAB; SINGLE CENTER RESULTS . EULAR 2023 (pp.1187-1183). Milan, Italy

ÖZDEMİR IŞIK, ÖZLEM Et Al. "AB0016 HEPATITIS B SEROPREVALENCE AND REACTIVATION FREQUENCY IN PATIENTS USING BIOLOGICAL DRUGS OTHER THAN RITUXIMAB; SINGLE CENTER RESULTS," EULAR 2023, Milan, Italy, 2023

ÖZDEMİR IŞIK, ÖZLEM Ö. Et Al. "AB0016 HEPATITIS B SEROPREVALENCE AND REACTIVATION FREQUENCY IN PATIENTS USING BIOLOGICAL DRUGS OTHER THAN RITUXIMAB; SINGLE CENTER RESULTS." EULAR 2023 , Milan, Italy, pp.1187-1183, 2023

ÖZDEMİR IŞIK, Ö. Et Al. (2023) . "AB0016 HEPATITIS B SEROPREVALENCE AND REACTIVATION FREQUENCY IN PATIENTS USING BIOLOGICAL DRUGS OTHER THAN RITUXIMAB; SINGLE CENTER RESULTS." EULAR 2023 , Milan, Italy, pp.1187-1183.

@conferencepaper{conferencepaper, author={ÖZLEM ÖZDEMİR IŞIK Et Al. }, title={AB0016 HEPATITIS B SEROPREVALENCE AND REACTIVATION FREQUENCY IN PATIENTS USING BIOLOGICAL DRUGS OTHER THAN RITUXIMAB; SINGLE CENTER RESULTS}, congress name={EULAR 2023}, city={Milan}, country={Italy}, year={2023}, pages={1187-1183} }